Associate Professor
Johns Hopkins
Baltimore, Maryland, United States
Errol L. Bush, M.D., FACS, Associate Professor of Surgery, is a thoracic surgeon and surgical director of the Advanced Lung Disease and Lung Transplant Program for the Johns Hopkins Comprehensive Transplant Center. He also serves as director of the Ex-vivo Lung Perfusion Program (EVLP).
Dr. Bush specializes in the surgical treatment of chronic and end stage lung diseases, as well as benign and malignant diseases and lesions of the chest. He is skilled in minimally invasive operations, including uniportal video-assisted thoracoscopic surgery (VATS). Dr. Bush also has significant experience with extracorporeal membrane oxygenation (ECMO).
Dr. Bush received his undergraduate degree from Emory University in 1999 and achieved his MD degree in 2003 at Duke University School of Medicine, where he was a Gates Foundation University Scholar and completed a cardiovascular research fellowship as a Stanley J. Sarnoff Fellow. He completed his general surgery training at Duke in 2010 before completing a Cardiothoracic residency at the University of California, San Francisco in 2013. After training, Dr. Bush remained on faculty at UCSF before being recruited to The Johns Hopkins Hospital in 2015 to assume his lung transplant leadership role.
His research interests include investigations of outcomes and health disparities related to lung cancer, lung transplant and ECMO patients. His basic science laboratory investigates T-cell mediated response to lung and kidney ischemia-reperfusion injury. As a clinical investigator he serves as the site-PI in several prospective multicenter investigations of organ perfusion and lung preservation systems, as well as currently recruiting patients for an international COVID19 oral therapy trial.
Hepatitis-C and Other Increased Risk Donors
Friday, January 26, 2024
11:20 AM – 11:35 AM CT
Navigating the Changing Landscape of Lung Transplant
Friday, January 26, 2024
12:00 PM – 12:45 PM CT
Session 3: Intraoperative Management
Friday, January 26, 2024
12:50 PM – 2:05 PM CT
Panel Discussion and Audience Q&A
Saturday, January 27, 2024
10:20 AM – 10:30 AM CT